Cargando…

The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK’s population-based Haematological Malignancy Research Network

BACKGROUND: Autoimmune inflammatory disease increases the risk of diffuse large B-cell lymphoma (DLBCL) and marginal zone lymphoma (MZL), but findings for other mature B-cell malignancies are equivocal. Furthermore, it has been suggested that the increase in DLBCL is due to the activated B-cell (ABC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kane, Eleanor, Painter, Daniel, Smith, Alexandra, Crouch, Simon, Oliver, Steven, Patmore, Russell, Roman, Eve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452783/ https://www.ncbi.nlm.nih.gov/pubmed/30844679 http://dx.doi.org/10.1016/j.canep.2019.02.014

Ejemplares similares

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2017)

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts
por: Roman, Eve, et al.
Publicado: (2022)

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
por: Lamb, Maxine JE, et al.
Publicado: (2019)

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2015)

Risk of mature B‐cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
por: Roman, Eve, et al.
Publicado: (2016)

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013)

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
por: Smith, Alexandra, et al.
Publicado: (2018)

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
por: Smith, Alexandra, et al.
Publicado: (2018)

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma
por: Smith, Alexandra, et al.
Publicado: (2015)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers—A qualitative study from the UK’s Haematological Malignancy Research Network
por: Howell, Debra A., et al.
Publicado: (2022)

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
por: Crouch, Simon, et al.
Publicado: (2022)

‘Unpacking’ pathways to lymphoma and myeloma diagnosis: Do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives
por: Howell, Debra, et al.
Publicado: (2020)

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
por: Smith, Alexandra, et al.
Publicado: (2010)

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)
por: Li, Jinlei, et al.
Publicado: (2016)

Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population‐based study
por: Howell, Debra, et al.
Publicado: (2017)

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data()
por: Wang, Han-I, et al.
Publicado: (2018)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
por: Howell, Debra A, et al.
Publicado: (2010)

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death
por: Howell, Debra A, et al.
Publicado: (2013)

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort
por: Wang, Han-I., et al.
Publicado: (2016)

Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers
por: McCaughan, Dorothy, et al.
Publicado: (2022)

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
por: Lamb, Maxine JE, et al.
Publicado: (2021)

Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers
por: Sheridan, Rebecca, et al.
Publicado: (2023)

Preferred and actual place of death in haematological malignancy
por: Howell, D A, et al.
Publicado: (2017)

Determinants of hospital death in haematological cancers: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

Myeloma: Patient accounts of their pathways to diagnosis
por: Howell, Debra A., et al.
Publicado: (2018)

Survival following relapse in childhood haematological malignancies diagnosed in 1974–2003 in Yorkshire, UK
por: Feltbower, R G, et al.
Publicado: (2007)

Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Haematological Findings in African Children in Uganda with Malignant Lymphoma
por: Stansfield, D.
Publicado: (1961)

Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences
por: Howell, Debra A, et al.
Publicado: (2019)

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort
por: Smith, A G, et al.
Publicado: (2014)

Contribution of rare and common coding variants to haematological malignancies in the UK biobank
por: Zöller, Bengt, et al.
Publicado: (2023)

EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018)

MYELOMA AND RELATED DISORDERS: CLINICS IN HAEMATOLOGY
Publicado: (1982)

Clinics in Haematology—Myeloma and Related Disorders
por: Scarffe, J. H.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_p0rdomc1oppmfcj7pvcpq1gt8s